Full Text
Full text is available in PDF
Official Journal of Research Center for Gastroenterology and Liver Diseases
e-ISSN 1735-3408
p-ISSN 1735-143X
Role of living donor liver transplantation in the treatment of hepatitis C virus infection
Authors
1Department of Surgery, Aristoteleion University of Thessaloniki, tsoulfasg@msn.com, Greece
2Department of Gastroenterology, Aristoteleion University of Thessaloniki, Greece
*Corresponding Author: Department of Surgery, Aristoteleion University of Thessaloniki, tsoulfasg@msn.com, Greece. Tel: 30-6971895190. Email: tsoulfasg@msn.com
Published online:Jun 30, 2011
Article type:Review Article
Received:Jan 02, 2011
Accepted:Apr 17, 2011
How to Cite:Tsoulfas G, Agorastou P. Role of living donor liver transplantation in the treatment of hepatitis C virus infection. Hepat Mon. 2011;11(6):. doi:
Abstract
Hepatitis C virus (HCV) infection is one of the most common indications for liver transplantation worldwide. Because of the existing organ shortage, adult-to-adult living donor liver transplantation (LDLT) has become an important method of expanding the donor pool to meet the ever-increasing need. However, despite advantages such as the quality of the hepatic graft and the timing of the transplant, the exact role of LDLT in the treatment of HCV is still unclear. In this review, we aim to address some of these issues in an effort to highlight both the advantages and disadvantages, as well as to identify the main challenges, of using LDLT for treating patients with HCV infection.
-
Implication for health policy/practice/research/medical education:
This paper addresses the role of an important resource of society (living donor liver transplantation) in the treatment of a very difficult disease (hepatitis C virus infection). -
Please cite this paper as:
Tsoulfas G, Agorastou P. Role of living donor liver transplantation in the treatment of hepatitis C virus infection. Hepat Mon. 2011;11(6):427-33.
2011 Kowsar M.P.Co. All rights reserved.
Highlights
Copyright
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
18
May
2021
Clinical Course and Outcome of Liver Transplantation in Patients with Hepatitis C in Iran
Fardad Ejtehadi,
Paymun Farahvashi,
Alireza Shamsaeefar,
Ramin Niknam,
Gholam Reza Sivandzadeh,
Ladan Aminlari
,et al.Ejtehadi F, Farahvashi P, Shamsaeefar A, Niknam R, Sivandzadeh GR, et al. Clinical Course and Outcome of Liver Transplantation in Patients with Hepatitis C in Iran. Hepat Mon. 2021;21(3):e108405. doi: https://doi.org/10.5812/hepatmon.108405
30
Nov
2011
Treatment of HCV Patients Before and After Renal Transplantation
Ling-yao Du,
Hong Tang
Du L, Tang H. Treatment of HCV Patients Before and After Renal Transplantation. Hepat Mon. 2011;11(11):. doi: https://doi.org/10.5812/kowsar.1735143X.712
30
Apr
2016
Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?
Hany M. Dabbous,
Iman F. Montasser,
Mohamed A. Sakr,
Rasha Refai,
Moataz Sayam,
Ahmed Abdelmonem
,et al.Dabbous HM, Montasser IF, Sakr MA, Refai R, Sayam M, et al. Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?. Hepat Mon. 2016;16(5):e35339. doi: https://doi.org/10.5812/hepatmon.35339
17
Jun
2017
Treatment of Hepatitis C Infection with Direct-Acting Antiviral Agents in Liver-Transplant Patients: A Systematic Review and Meta-Analysis
Mohammad Saeid Rezaee-Zavareh,
Khashayar Hesamizadeh,
Heidar Sharafi,
Seyed Moayed Alavian
Rezaee-Zavareh MS, Hesamizadeh K, Sharafi H, Alavian SM. Treatment of Hepatitis C Infection with Direct-Acting Antiviral Agents in Liver-Transplant Patients: A Systematic Review and Meta-Analysis. Hepat Mon. 2017;17(6):e12324. doi: https://doi.org/10.5812/hepatmon.12324
30
Dec
2012
Management of Hepatitis B Virus Infection in Liver Transplantation Setting; The Rising Concerns and Growing Hopes, Report From 10th Congress of the Iranian Society for Organ Transplantation, 2011, Shiraz, Iran
Seyed Moayed Alavian,
Kamran B. Lankarani,
Mario Rizzetto,
Alfredo Marzano,
Mohsen Moghadami,
Saman Nik-Eghbolian
,et al.Alavian SM, B. Lankarani K, Rizzetto M, Marzano A, Moghadami M, et al. Management of Hepatitis B Virus Infection in Liver Transplantation Setting; The Rising Concerns and Growing Hopes, Report From 10th Congress of the Iranian Society for Organ Transplantation, 2011, Shiraz, Iran. Hepat Mon. 2012;12(12):8094. doi: https://doi.org/10.5812/hepatmon.8094
Cited by
- Scopus by DOI: 0
Last Update: 3 weeks ago
- Scopus by Title: 3
Last Update: 3 weeks ago
- Scopus by Title (Ref): 3
Last Update: 3 weeks ago
- CrossRef: 0
Last Update: 4 hours ago
- OpenAlex: 0
Last Update: 6 hours ago
- OpenCitations: 0
Last Update: 4 days ago
Comments
Number of Comments:0